Recent Finacing
Recent Raise
Cebix is a biopharmaceutical company developing ERSATTA, a once-weekly C‑peptide therapy for type 1 diabetes complications, conducting Phase 1/2 studies and a planned Phase 2b peripheral neuropathy trial.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors